Association of Auditory Hallucinations and Anticonvulsant Hypersensitivity Syndrome with Carbamazepine Treatment

Carbamazepine is effective in the treatment of acute mania and in the prevention of episodes in bipolar disorder, and it may also be useful in depression, impulse-control disorder and withdrawal from alcohol and benzodiazepine dependence. A potentially life-threatening side effect is the anticonvulsant hypersensitivity syndrome. Here, we describe a patient who developed severe auditory hallucinations followed by a distinct hypersensitivity syndrome most likely induced by carbamazepine treatment.

References

• 1 Benatar M, Sahin M, Davis R. Antiepileptic drug-induced visual hallucinations in a child.  Pediatr Neurol. 2000;  23 439-441
• 2 Berger H. An unusual manifestation of Tegretol (carbamazepine) toxicity.  Ann Intern Med. 1971;  74 449-450
• 3 Dalby MA. Antiepileptic and psychotropic effect of carbamazepine (Tegretol) in the treatment of psychomotor epilepsy.  Epilepsia. 1971;  12 325-334
• 4 Degner D, Kropp S, Porzig J, Grohmann R, Ruther E. Pseudohallucinations associated with moclobemide: a case report.  Pharmacopsychiatry. 2005;  38 179-181
• 5 Franks RD, Richter AJ. Schizophrenia-like psychosis associated with anticonvulsant toxicity.  Am J Psychiatry. 1979;  136 973-974
• 6 Knowles SR, Shapiro LE, Shear NH. Anticonvulsant hypersensitivity syndrome: incidence, prevention and management.  Drug Saf. 1999;  21 489-501
• 7 Malcolm R, Myrick H, Roberts J, Wang W, Anton RF, Ballenger JC. The effects of carbamazepine and lorazepam on single versus multiple previous alcohol withdrawals in an outpatient randomized trial.  J Gen Intern Med. 2002;  17 349-355
• 8 Mckee RJW, Larkin JG, Brodie MJ. Acute psychosis with carbamazepine and sodium valproate.  Lancet. 1989;  333 167
• 9 Post RM, Uhde TW, Roy-Byrne PP, Joffe RT. Antidepressant effects of carbamazepine.  Am J Psychiatry. 1986;  143 29-34
• 10 Prueter C, Waberski TD, Norra C, Podoll K. Palinacousis leading to the diagnosis of temporal lobe seizures in a patient with schizophrenia.  Seizure. 2002;  11 198-200
• 11 Schweizer E, Rickels K, Case WG, Greenblatt DJ. Carbamazepine treatment in patients discontinuing long-term benzodiazepine therapy. Effects on withdrawal severity and outcome.  Arch Gen Psychiatry. 1991;  48 448-452
• 12 Stewart B, Brennan DM. Auditory hallucinations after right temporal gyri resection.  J Neuropsychiatry Clin Neurosci. 2005;  17 243-245
• 13 Tariot PN, Erb R, Podgorski CA, Cox C, Patel S, Jakimovich L. et al . Efficacy and tolerability of carbamazepine for agitation and aggression in dementia.  Am J Psychiatry. 1998;  155 54-61
• 14 Weaver DF, Camfield P, Fraser A. Massive carbamazepine overdose: clinical and pharmacologic observations in five episodes.  Neurology. 1988;  38 755-759

Correspondence